From the PrognoScan database, high expression of ITGA3 showed favorable prognosis in breast cancer (Figure 4A) and eye cancer (Figure 4B), and poor prognosis in colorectal cancer (Figure 4C), lung adenocarcinoma (Figure 4D), non-small-cell lung cancer (Figure 4E) and ovarian cancer (Figure 4F). This evidence concerns the gene ITGA3 and non-small cell lung carcinoma.